aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Amalgam Rx is a digital health company focused on innovating chronic care delivery through validated technologies. For over 15 years, Amalgam Rx has collaborated with leading life sciences companies to develop and scale digital solutions that integrate seamlessly into electronic health records (EHR) and mobile devices. The firm’s platform supports a variety of business models, enabling better healthcare decisions within provider workflows and patients’ everyday lives.
Amalgam Rx’s investment philosophy centers on creating lasting change in the chronic care ecosystem by leveraging their innovative platform and proven end-to-end methodology. Key partners include many of the world’s leading life sciences companies, highlighting their strong industry relationships. The firm offers unique value-add services such as EHR integration and data insights, ensuring that their digital products are both effective and scalable.
Also Known As
Amalgam RX, Inc.
Operating Status
Active
Amalgam Rx Address
Wilmington,
North Carolina
28403
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts